FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

421816000: Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4596692015 Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module
4596693013 Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Is a Product containing betamethasone and calcipotriol false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has active ingredient Calcipotriol false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has active ingredient Vitamin D and/or vitamin D derivative false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form Conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Is a Product containing betamethasone in topical dosage form false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator unit milligram false Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator unit milligram false Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator unit nanogram false Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator unit nanogram false Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Is a Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator value 500 false Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has precise active ingredient Calcipotriol true Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator value 50 false Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has precise active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator unit microgram true Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength denominator unit gram true Inferred relationship Existential restriction modifier 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start